Ehsan, M.; Ahmed, S.; Majeed, W.; Iftikhar, A.; Iftikhar, M.; Abbas, M.; Mehmood, T.
Rhoifolin Improves Glycometabolic Control in Streptozotocin-Induced Diabetic Rats by Up-Regulating the Expression of Insulin Signaling Proteins and Down-Regulating the MAPK/JNK Pathway. Pharmaceuticals 2025, 18, 361.
https://doi.org/10.3390/ph18030361
AMA Style
Ehsan M, Ahmed S, Majeed W, Iftikhar A, Iftikhar M, Abbas M, Mehmood T.
Rhoifolin Improves Glycometabolic Control in Streptozotocin-Induced Diabetic Rats by Up-Regulating the Expression of Insulin Signaling Proteins and Down-Regulating the MAPK/JNK Pathway. Pharmaceuticals. 2025; 18(3):361.
https://doi.org/10.3390/ph18030361
Chicago/Turabian Style
Ehsan, Maryam, Sibtain Ahmed, Wafa Majeed, Asra Iftikhar, Maryam Iftikhar, Mateen Abbas, and Tahir Mehmood.
2025. "Rhoifolin Improves Glycometabolic Control in Streptozotocin-Induced Diabetic Rats by Up-Regulating the Expression of Insulin Signaling Proteins and Down-Regulating the MAPK/JNK Pathway" Pharmaceuticals 18, no. 3: 361.
https://doi.org/10.3390/ph18030361
APA Style
Ehsan, M., Ahmed, S., Majeed, W., Iftikhar, A., Iftikhar, M., Abbas, M., & Mehmood, T.
(2025). Rhoifolin Improves Glycometabolic Control in Streptozotocin-Induced Diabetic Rats by Up-Regulating the Expression of Insulin Signaling Proteins and Down-Regulating the MAPK/JNK Pathway. Pharmaceuticals, 18(3), 361.
https://doi.org/10.3390/ph18030361
